301201 诚达药业
已收盘 07-23 15:00:00
资讯
新帖
简况
诚达药业:公司2024年半年度报告预约披露时间为2024年8月28日,届时敬请留意查阅
证券之星 · 07-16
诚达药业:公司2024年半年度报告预约披露时间为2024年8月28日,届时敬请留意查阅
诚达药业(301201.SZ)拟10股派2元 于7月10日除权除息
智通财经网 · 07-02
诚达药业(301201.SZ)拟10股派2元 于7月10日除权除息
诚达药业:截至目前,公司未开展相关业务
证券之星 · 05-28
诚达药业:截至目前,公司未开展相关业务
【机构调研记录】金信基金调研生益电子、诚达药业
证券之星 · 05-27
【机构调研记录】金信基金调研生益电子、诚达药业
诚达药业:截至目前,公司除权除息后的发行价为44.96元/股
证券之星 · 05-21
诚达药业:截至目前,公司除权除息后的发行价为44.96元/股
诚达药业:目前,公司暂无辉瑞原料药工厂在手订单,应披露信息请以公司公告为准
证券之星 · 05-14
诚达药业:目前,公司暂无辉瑞原料药工厂在手订单,应披露信息请以公司公告为准
诚达药业(301201.SZ)累计回购2.03%股份 耗资5526.67万元
智通财经 · 05-07
诚达药业(301201.SZ)累计回购2.03%股份 耗资5526.67万元
诚达药业(301201)2024年一季报简析:净利润减5.09%
证券之星 · 04-23
诚达药业(301201)2024年一季报简析:净利润减5.09%
诚达药业(301201.SZ)发布2023年度业绩,净利润9098.03万元,下降14.56%
智通财经网 · 04-21
诚达药业(301201.SZ)发布2023年度业绩,净利润9098.03万元,下降14.56%
诚达药业跌6.76% 2022年上市即巅峰超募11亿元
中国经济网 · 03-05
诚达药业跌6.76% 2022年上市即巅峰超募11亿元
诚达药业:首次回购0.01%股份 支付总金额为20.70万元
财华社 · 01-23
诚达药业:首次回购0.01%股份 支付总金额为20.70万元
加载更多
公司概况
公司名称:
诚达药业股份有限公司
所属行业:
医药制造业
上市日期:
2022-01-20
主营业务:
诚达药业股份有限公司主要致力于为跨国制药企业及医药研发机构提供关键医药中间体、原料药CDMO服务,并从事左旋肉碱系列产品的研发、生产和销售。公司主要产品及服务是预临床及临床阶段新药CDMO服务、已上市药物CDMO服务、仿制药中间体CDMO服务、食品添加剂、饲料添加剂、原料药。公司是国内最早实现左旋肉碱系列产品产业化的企业之一,也是全球左旋肉碱主要供应商之一。产品产业链齐全,包括食品添加剂、饲料添加剂、原料药,产品出口全球30多个国家和地区。
发行价格:
72.69
{"stockData":{"symbol":"301201","market":"SZ","secType":"STK","nameCN":"诚达药业","latestPrice":18.26,"timestamp":1721718204000,"preClose":18.75,"halted":0,"volume":1011082,"delay":0,"floatShares":87193799,"shares":155000000,"eps":0.5816,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.49,"latestTime":"07-23 15:00:00","open":18.75,"high":18.75,"low":18.23,"amount":18651000,"amplitude":0.0277,"askPrice":18.26,"askSize":83,"bidPrice":18.24,"bidSize":102,"shortable":0,"etf":0,"ttmEps":0.5816,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721784600000},"adr":0,"adjPreClose":18.75,"symbolType":"stock","openAndCloseTimeList":[[1721698200000,1721705400000],[1721710800000,1721718000000]],"highLimit":20.63,"lowLimit":16.88,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":154713824,"pbRate":1.29,"roa":"--","roe":"0.82%","epsLYR":0.5881,"committee":-0.012132,"marketValue":2825000000,"floatMarketCap":1592000000,"peRate":31.396148,"changeRate":-0.0261,"turnoverRate":0.0116,"status":1},"requestUrl":"/m/hq/s/301201","defaultTab":"news","newsList":[{"id":"2451541961","title":"诚达药业:公司2024年半年度报告预约披露时间为2024年8月28日,届时敬请留意查阅","url":"https://stock-news.laohu8.com/highlight/detail?id=2451541961","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451541961?lang=zh_cn&edition=full","pubTime":"2024-07-16 18:04","pubTimestamp":1721124265,"startTime":"0","endTime":"0","summary":"证券之星消息,诚达药业(301201)07月16日在投资者关系平台上答复投资者关心的问题。投资者:为什么公司到现在还没发布中报业绩预告?是不符合预告条件吗?诚达药业董秘:尊敬的投资者您好,公司2024年半年度报告预约披露时间为2024年8月28日,届时敬请留意查阅。感谢您的关注!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600036469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"gpt_icon":0},{"id":"2448361371","title":"诚达药业(301201.SZ)拟10股派2元 于7月10日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2448361371","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448361371?lang=zh_cn&edition=full","pubTime":"2024-07-02 18:07","pubTimestamp":1719914849,"startTime":"0","endTime":"0","summary":"诚达药业(301201.SZ)公告,公司2023年度权益分派拟:向全体股东每10股...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/19.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/19.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1144456.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","301201"],"gpt_icon":0},{"id":"2438325023","title":"诚达药业:截至目前,公司未开展相关业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2438325023","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438325023?lang=zh_cn&edition=full","pubTime":"2024-05-28 18:04","pubTimestamp":1716890673,"startTime":"0","endTime":"0","summary":"投资者:公司目前买了多少理财产品,每年初步可以给公司带来多少利润诚达药业董秘:尊敬的投资者您好,公司于2024年1月12日召开的2024年第一次临时股东大会审议通过了《关于使用闲置募集资金进行现金管理的议案》、《关于使用闲置自有资金进行现金管理的议案》,在该日期后的12个月内,公司使用闲置募集资金、自有资金进行现金管理的额度分别为10亿元、7亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052800033243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"gpt_icon":0},{"id":"2438109188","title":"【机构调研记录】金信基金调研生益电子、诚达药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2438109188","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438109188?lang=zh_cn&edition=full","pubTime":"2024-05-27 08:02","pubTimestamp":1716768153,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及5月24日披露的机构调研信息,金信基金近期对2家上市公司进行了调研,相关名单如下:1)生益电子 个股亮点:公司具备800G光模块的技术能力,且已经给部分客户供货。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052700000500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","688183","BK0239","BK0214"],"gpt_icon":0},{"id":"2437499733","title":"诚达药业:截至目前,公司除权除息后的发行价为44.96元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2437499733","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437499733?lang=zh_cn&edition=full","pubTime":"2024-05-21 17:06","pubTimestamp":1716282400,"startTime":"0","endTime":"0","summary":"证券之星消息,诚达药业05月21日在投资者关系平台上答复投资者关心的问题。诚达药业董秘:尊敬的投资者您好,截至目前,公司除权除息后的发行价为44.96元/股。权益分派将于股东大会审议通过后2个月内实施,本次权益分派的除权除息价请您关注公司后续披露的2023年年度权益分派实施公告,以公告信息为准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024052100028861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"gpt_icon":0},{"id":"2435593994","title":"诚达药业:目前,公司暂无辉瑞原料药工厂在手订单,应披露信息请以公司公告为准","url":"https://stock-news.laohu8.com/highlight/detail?id=2435593994","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435593994?lang=zh_cn&edition=full","pubTime":"2024-05-14 18:04","pubTimestamp":1715681056,"startTime":"0","endTime":"0","summary":"投资者:贵公司2022年受辉瑞原料药工厂委托,为其定制研发医药中间体,包括PF-07304814中间体。请问现在与辉瑞原料药工厂有业务往来与否,有订单与否?","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400027283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"gpt_icon":0},{"id":"2433285832","title":"诚达药业(301201.SZ)累计回购2.03%股份 耗资5526.67万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433285832","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433285832?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:21","pubTimestamp":1715070063,"startTime":"0","endTime":"0","summary":"智通财经APP讯,诚达药业(301201.SZ)公告,公司截至2024年4月30日以集中竞价交易方式已累计回购公司股份313.75万股,占公司目前总股本的比例为2.03%,交易总金额为5526.67万元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1118157.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","301201"],"gpt_icon":0},{"id":"2429902716","title":"诚达药业(301201)2024年一季报简析:净利润减5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429902716","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429902716?lang=zh_cn&edition=full","pubTime":"2024-04-23 06:09","pubTimestamp":1713823770,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期诚达药业发布2024年一季报。根据财报显示,本报告期中诚达药业净利润减5.09%。截至本报告期末,公司营业总收入1.01亿元,同比下降1.28%,归母净利润1864.45万元,同比下降5.09%。公司最新一期年度报表的现金流为正,经营性现金流比利润高太多,建议确认原因。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300009903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201"],"gpt_icon":0},{"id":"2429398950","title":"诚达药业(301201.SZ)发布2023年度业绩,净利润9098.03万元,下降14.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429398950","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429398950?lang=zh_cn&edition=full","pubTime":"2024-04-21 16:09","pubTimestamp":1713686940,"startTime":"0","endTime":"0","summary":"诚达药业发布2023年年度报告,该公司营业收入为4.14亿元,同比增长0.69%。归属于上市公司股东的净利润为9098.03万元,同比减少14.56%。因公司长期的项目储备和布局,原料药及医药中间体业务在2023年取得了不错的增长业绩,原料药系列实现销售收入1.19亿元,同比增长217.14%;医药中间体系列实现销售收入1.67亿元,同比增长8.64%。肉碱系列产品销售数量同比增长13.85%,但因受市场情况影响,销售单价同比下降49.48%,实现销售收入1.26亿元,同比下降42.48%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-21/doc-inasqtfu3034200.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-21/doc-inasqtfu3034200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301201"],"gpt_icon":0},{"id":"2417874450","title":"诚达药业跌6.76% 2022年上市即巅峰超募11亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417874450","media":"中国经济网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417874450?lang=zh_cn&edition=full","pubTime":"2024-03-05 15:44","pubTimestamp":1709624640,"startTime":"0","endTime":"0","summary":" 上市首日,诚达药业盘中最高报188.00元,创上市以来股价最高点。 诚达药业首次公开发行股票募集资金总额为175,721.06万元,扣除发行费用后募集资金净额162,144.75万元。诚达药业实际募资净额比原拟募集资金多110,816.71万元。 诚达药业首次公开发行股票的发行费用总额为13,576.31万元,其中光大证券获得保荐承销费用11,792.90万元。 2023年7月3日,诚达药业发布2022年度权益分派实施公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-03-05/doc-inamheuk9824272.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-03-05/doc-inamheuk9824272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","301201"],"gpt_icon":0},{"id":"2405107231","title":"诚达药业:首次回购0.01%股份 支付总金额为20.70万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2405107231","media":"财华社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2405107231?lang=zh_cn&edition=full","pubTime":"2024-01-23 17:44","pubTimestamp":1706003096,"startTime":"0","endTime":"0","summary":"诚达药业(301201)公告称,1月23日,公司首次通过股份回购专用证券账户以集中竞价交易方式实施股份回购,回购公司股份数量为9,900股,占公司总股本的0.01%,回购股份的最高成交价为20.94元/股,最低成交价为20.77元/股,支付总金额为206,987.00元(不含交易费用)。","market":"us","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/65af8ae753243c07837547b6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK0239","301201"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-01-20","address":"浙江省嘉兴市嘉善县惠民街道黄河路36号","stockEarnings":[{"period":"1week","weight":0.0291},{"period":"1month","weight":-0.0211},{"period":"3month","weight":0.0194},{"period":"6month","weight":-0.0997},{"period":"1year","weight":-0.2521},{"period":"ytd","weight":-0.2544}],"companyName":"诚达药业股份有限公司","boardCode":"AI0027","perCapita":"5651股","boardName":"医药制造业","registeredCapital":"15471万元","compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0113},{"period":"3month","weight":-0.0191},{"period":"6month","weight":0.0509},{"period":"1year","weight":-0.0642},{"period":"ytd","weight":-0.0036}],"survey":" 诚达药业股份有限公司主要致力于为跨国制药企业及医药研发机构提供关键医药中间体、原料药CDMO服务,并从事左旋肉碱系列产品的研发、生产和销售。公司主要产品及服务是预临床及临床阶段新药CDMO服务、已上市药物CDMO服务、仿制药中间体CDMO服务、食品添加剂、饲料添加剂、原料药。公司是国内最早实现左旋肉碱系列产品产业化的企业之一,也是全球左旋肉碱主要供应商之一。产品产业链齐全,包括食品添加剂、饲料添加剂、原料药,产品出口全球30多个国家和地区。","serverTime":1721750354508,"listedPrice":72.69,"stockholders":"15429人(较上一季度减少9.53%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诚达药业(301201)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诚达药业(301201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诚达药业,301201,诚达药业股票,诚达药业股票老虎,诚达药业股票老虎国际,诚达药业行情,诚达药业股票行情,诚达药业股价,诚达药业股市,诚达药业股票价格,诚达药业股票交易,诚达药业股票购买,诚达药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诚达药业(301201)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诚达药业(301201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}